| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |